rs1554337983
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PM2PP3
The NM_002047.4(GARS1):c.818C>T(p.Ser273Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease type 2DInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- neuronopathy, distal hereditary motor, type 5AInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
- spinal muscular atrophy, infantile, James typeInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GARS1 | ENST00000389266.8 | c.818C>T | p.Ser273Phe | missense_variant | Exon 7 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
| GARS1 | ENST00000675651.1 | c.818C>T | p.Ser273Phe | missense_variant | Exon 7 of 17 | ENSP00000502513.1 | ||||
| GARS1 | ENST00000675810.1 | c.716C>T | p.Ser239Phe | missense_variant | Exon 6 of 16 | ENSP00000502743.1 | ||||
| GARS1 | ENST00000675693.1 | c.650C>T | p.Ser217Phe | missense_variant | Exon 8 of 18 | ENSP00000502174.1 | ||||
| GARS1 | ENST00000675051.1 | c.617C>T | p.Ser206Phe | missense_variant | Exon 7 of 17 | ENSP00000502296.1 | ||||
| GARS1 | ENST00000674815.1 | c.449C>T | p.Ser150Phe | missense_variant | Exon 7 of 17 | ENSP00000502799.1 | ||||
| GARS1 | ENST00000674851.1 | c.449C>T | p.Ser150Phe | missense_variant | Exon 8 of 18 | ENSP00000502451.1 | ||||
| GARS1 | ENST00000444666.6 | n.818C>T | non_coding_transcript_exon_variant | Exon 7 of 18 | 3 | ENSP00000415447.2 | ||||
| GARS1 | ENST00000674616.1 | n.*532C>T | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674643.1 | n.818C>T | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000501636.1 | |||||
| GARS1 | ENST00000674737.1 | n.*156C>T | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000674807.1 | n.818C>T | non_coding_transcript_exon_variant | Exon 7 of 16 | ENSP00000502814.1 | |||||
| GARS1 | ENST00000675529.1 | n.*688C>T | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000675859.1 | n.818C>T | non_coding_transcript_exon_variant | Exon 7 of 15 | ENSP00000502033.1 | |||||
| GARS1 | ENST00000676088.1 | n.*760C>T | non_coding_transcript_exon_variant | Exon 9 of 19 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676140.1 | n.818C>T | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000502571.1 | |||||
| GARS1 | ENST00000676164.1 | n.*269C>T | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*107C>T | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*250C>T | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000501980.1 | |||||
| GARS1 | ENST00000676403.1 | n.818C>T | non_coding_transcript_exon_variant | Exon 7 of 16 | ENSP00000502681.1 | |||||
| GARS1 | ENST00000674616.1 | n.*532C>T | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674737.1 | n.*156C>T | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000675529.1 | n.*688C>T | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000676088.1 | n.*760C>T | 3_prime_UTR_variant | Exon 9 of 19 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676164.1 | n.*269C>T | 3_prime_UTR_variant | Exon 7 of 17 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*107C>T | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*250C>T | 3_prime_UTR_variant | Exon 7 of 17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460966Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726852 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). ClinVar contains an entry for this variant (Variation ID: 543165). This variant has not been reported in the literature in individuals affected with GARS-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 273 of the GARS protein (p.Ser273Phe). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at